Myleran

Active Ingredient(s): Busulfan
FDA Approved: * June 26, 1954
Pharm Company: * GLAXOSMITHKLINE
Category: Cancer

Busulfan (Myleran, GlaxoSmithKline, Busulfex IV, Otsuka America Pharmaceutical, Inc.) is a chemotherapy drug in use since 1959. It is a cell cycle non-specific alkylating antineoplastic agent, in the class of alkyl sulfonates. Its chemical designation is 1,4-butanediol dimethanesulfonate. Contents 1 History 2 Indications 3 Availability 4 Side effects 5 Dosing, administration, and pharmacokinetics 6 Drug interactions 7 Pharmacology 8 Complexation 9 References 10 External links History B... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Myleran GX;EF3;M
Myleran 2 mg Oral Tablet
NDC: 0173-0713
Labeler:
Glaxosmithkline LLC
Myleran GX;EF3;M
Myleran 2 mg Oral Tablet
NDC: 76388-713
Labeler:
Aspen Global Inc.
Myleran 2 mg Oral Tablet, Film Coated
NDC: 69784-620
Labeler:
Woodward Pharma Services LLC
Myleran 2 mg Oral Tablet, Film Coated
NDC: 80725-620
Labeler:
Waylis Therapeutics LLC

Related Brands

Drugs with the same active ingredients